39 patents
Utility
Polo like kinase 4 inhibitors
2 Jan 24
Chudi Ndubaku, Jared Thomas Moore, Paul Anthony Gibbons, Jae Hyuk Chang, F. Anthony Romero, Xiaohui Du, Hiroyuki Kawai, Stephane Ciblat, Hong Wang, Vincent Albert, Lea Constantineau-Forget, Hugo De Almeida Silva, Dilan Emine Polat, Amit Nayyar, Daniel Gordon Michael Shore, Kejia Wu, Joanne Tan
Filed: 27 Apr 23
Utility
Polo Like Kinase 4 Inhibitors
16 Nov 23
Chudi NDUBAKU, Jared Thomas MOORE, Paul Anthony GIBBONS, Jae Hyuk CHANG, F. Anthony ROMERO, Xiaohui DU, Hiroyuki KAWAI, Stephane CIBLAT, Hong WANG, Vincent ALBERT, Lea CONSTANTINEAU-FORGET, Hugo de Almeida SILVA, Dilan Emine POLAT, Amit NAYYAR, Daniel Gordon Michael SHORE, Kejia WU, Joanne TAN
Filed: 27 Apr 23
Utility
CD73 inhibitors
7 Nov 23
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds.
Xiaohui Du, John Eksterowicz, Valeria R. Fantin, Daqing Sun, Qiuping Ye, Jared Moore, Tatiana Zavorotinskaya, Brian R. Blank, Yosup Rew, Kejia Wu, Liusheng Zhu, Johnny Pham, Hiroyuki Kawai
Filed: 17 Mar 22
Utility
Uses of Glucocorticoid Receptor (GR) Antagonist and Androgen Receptor (Ar) Degrader Combinations
28 Sep 23
Disclosed herein are methods of treating prostate cancer in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of (i) a glucocorticoid receptor (GR) antagonist and (ii) an androgen receptor (AR) degrader.
Haiying ZHOU, Lori S. FRIEDMAN, Shravani BARKUND, Anneleen DAEMEN
Filed: 3 Aug 21
Utility
CD73 Inhibitors
27 Apr 23
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds.
Xiaohui DU, John EKSTEROWICZ, Valeria R. FANTIN, Daqing SUN, Qiuping YE, Jared MOORE, Tatiana ZAVOROTINSKAYA, Brian R. BLANK, Yosup REW, Kejia WU, Liusheng ZHU, Johnny PHAM, Hiroyuki KAWAI, Chien-Hung YEH
Filed: 31 Oct 22
Utility
Inhibitors of Glucocorticoid Receptor
30 Mar 23
The present invention relates generally to compositions and methods for treating cancer and hypercortisolism.
Daqing SUN, Lawrence R. McGEE, Xiaohui DU, Liusheng ZHU, Xuelei YAN, Yosup REW, John EKSTEROWICZ, Julio C. MEDINA, Valeria R. FANTIN, Haiying ZHOU, Minna Delarae BALBAS
Filed: 15 Aug 22
Utility
CD73 inhibitors
14 Feb 23
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds.
Xiaohui Du, John Eksterowicz, Valeria R. Fantin, Erica L. Jackson, Daqing Sun, Qiuping Ye, Jared Moore
Filed: 17 Aug 21
Utility
CD73 Inhibitors
29 Dec 22
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds.
Xiaohui DU, John EKSTEROWICZ, Valeria R. FANTIN, Daqing SUN, Qiuping YE, Jared MOORE, Tatiana ZAVOROTINSKAYA, Brian R. BLANK, Yosup REW, Kejia WU, Liusheng ZHU, Johnny PHAM, Hiroyuki KAWAI, Chien-Hung YEH
Filed: 29 Oct 20
Utility
CD73 inhibitors
20 Dec 22
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds.
Xiaohui Du, John Eksterowicz, Valeria R. Fantin, Daqing Sun, Qiuping Ye, Jared Moore, Tatiana Zavorotinskaya, Brian R. Blank, Yosup Rew, Kejia Wu, Liusheng Zhu, Johnny Pham, Hiroyuki Kawai, Chien-Hung Yeh
Filed: 29 Oct 20
Utility
CD73 Inhibitors
20 Oct 22
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds.
Xiaohui DU, John EKSTEROWICZ, Valeria R. FANTIN, Daqing SUN, Qiuping YE, Jared MOORE, Tatiana ZAVOROTINSKAYA, Brian R. BLANK, Hiroyuki KAWAI, Chien-Hung YEH, Yosup REW, Kejia WU, Johnny PHAM
Filed: 15 Jul 20
Utility
CD73 Inhibitors
18 Aug 22
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds.
Xiaohui DU, John EKSTEROWICZ, Valeria R. FANTIN, Erica L. JACKSON, Daqing SUN, Qiuping YE, Jared MOORE, Tatiana ZAVOROTINSKAYA
Filed: 18 Apr 22
Utility
CD73 Inhibitors
14 Jul 22
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds.
Xiaohui DU, John EKSTEROWICZ, Valeria R. FANTIN, Daqing SUN, Qiuping YE, Jared MOORE, Tatiana ZAVOROTINSKAYA, Brian R. BLANK, Yosup REW, Kejia WU, Liusheng ZHU, Johnny PHAM, Hiroyuki KAWAI
Filed: 17 Mar 22
Utility
CD73 inhibitors
5 Jul 22
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds.
Xiaohui Du, John Eksterowicz, Valeria R. Fantin, Erica L. Jackson, Daqing Sun, Qiuping Ye, Jared Moore, Tatiana Zavorotinskaya
Filed: 2 Nov 18
Utility
CD73 inhibitors
10 May 22
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds.
Xiaohui Du, John Eksterowicz, Valeria R. Fantin, Daqing Sun, Qiuping Ye, Jared Moore, Tatiana Zavorotinskaya, Brian R. Blank, Yosup Rew, Kejia Wu, Liusheng Zhu, Johnny Pham, Hiroyuki Kawai
Filed: 23 Oct 20
Utility
Glucocorticoid Receptor Modulators
17 Mar 22
Described herein are glucocorticoid receptor modulators and pharmaceutical compositions comprising said compounds.
Xiaohui DU, John EKSTEROWICZ, Valeria R. FANTIN, Yosup REW, Daqing SUN, Qiuping YE, Haiying ZHOU, Hiroyuki KAWAI, Jared MOORE, Johnny PHAM, Kejia WU, Liusheng ZHU
Filed: 9 Oct 19
Utility
CD73 Inhibitors
24 Feb 22
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds.
Xiaohui DU, John EKSTEROWICZ, Valeria R. FANTIN, Erica L. JACKSON, Daqing SUN, Qiuping YE, Jared MOORE
Filed: 17 Aug 21
Utility
Inhibitors of glucocorticoid receptor
28 Dec 21
The present invention relates generally to compositions and methods for treating cancer and hypercortisolism.
Daqing Sun, Lawrence R. McGee, Xiaohui Du, Liusheng Zhu, Xuelei Yan, Yosup Rew, John Eksterowicz, Julio C. Medina, Haiying Zhou, Minna Delarae Balbas, Valeria R. Fantin
Filed: 22 Dec 16
Utility
Inhibitors of Glucocorticoid Receptor
23 Dec 21
The present invention relates generally to compositions and methods for treating cancer and hypercortisolism.
Daqing SUN, Lawrence R. McGEE, Xiaohui DU, Liusheng ZHU, Xuelei YAN, Yosup REW, John EKSTEROWICZ, Julio C. MEDINA, Haiying ZHOU, Minna Delarae BALBAS, Valeria R. FANTIN
Filed: 17 Aug 21
Utility
Inhibitors of Glucocorticoid Receptor
9 Dec 21
The present invention relates generally to compositions and methods for treating cancer and hypercortisolism.
Daqing SUN, Lawrence R. McGEE, Xiaohui DU, Liusheng ZHU, Xuelei YAN, Yosup REW, John EKSTEROWICZ, Julio C. MEDINA, Haiying ZHOU, Minna Delarae BALBAS, Valeria R. FANTIN
Filed: 21 Jul 21
Utility
CD73 inhibitors
28 Sep 21
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds.
Xiaohui Du, John Eksterowicz, Valeria R. Fantin, Erica L. Jackson, Daqing Sun, Qiuping Ye, Jared Moore
Filed: 9 May 18